Quick answer
What is BPC-157?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works
BPC-157 is a peptide, grouped on this site under Tissue repair peptides, and the 12 research records kept here are 8 from studies in rats or mice and 4 that do not state what kind of study it is.
The literature search returned 226 records. This site keeps 12 of them, which is 5.3 per cent of what came back.
What it is
This site puts it in the Tissue repair peptides group.
The retrieved literature frames the mechanism in terms of a relation to the nitric oxide system, and reports effects on growth hormone receptor expression in tendon fibroblasts. No single receptor target is established in the retrieved record set.[1, 2]
Stated in the titles of the cited 2014 Current Pharmaceutical Design and 2014 Molecules papers.
What kind of records
The records kept here are animal and laboratory studies only.
That sentence is produced by counting, not by reading. What was counted: no interventional human trial record; 8 rodent and 0 in vitro records among 12.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 214 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des (2014). pmid:23755725
- Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules (2014). pmid:25415472